BL-M07D1
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for BL-M07D1, covering 2025-08-03 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer [Phase 3]